Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B A Van Hout

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Health Economics|December 9, 1998
Discounting costs and effects: a reconsiderationB A van Hout
Scandinavian Journal of Gastroenterology. Supplement|January 28, 2004
Whom and how to treat: weighing the costs and effectsB A van Hout
Health Economics|December 5, 2000
A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplastyM J Al, B A Van Hout
Nederlands Tijdschrift Voor Geneeskunde|November 12, 1994
[Is the use of helicopters with a trauma team in severely injured accident victims in The Netherlands cost effective? A modelling approach]B C Michel, B A van Hout
European Heart Journal|May 15, 2001
Cost-effectiveness of HMG coenzyme reductase inhibitors; whom to treat?B A van Hout, M L Simoons
European Heart Journal|November 1, 1995
Costs and effects of c7E3 in high risk PTCA patients. An indirect analysis for The NetherlandsB A van Hout, M L Simoons
European Heart Journal|August 3, 2001
Cost-efficacy in interventional cardiology; results from the EPISTENT study. Evaluation of Platelet IIb/IIIa Inhibitor For Stenting TrialJ E Zwart-van Rijkom, B A van Hout
Epilepsia|January 1, 1997
Current issues in the management of epilepsy: the impact of frequent seizures on cost of illness, quality of life, and mortalityG A Baker, L Nashef, B A van Hout
Bailliere'S Clinical Gastroenterology|September 1, 1994
Assessing the benefits of transplant servicesB C Michel, B A Van Hout, G J Bonsel
Heart (British Cardiac Society)|August 18, 2004
Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II)P W Serruys, P A Lemos, B A van Hout, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Health Economics|December 9, 1998
Discounting costs and effects: a reconsiderationB A van Hout
Scandinavian Journal of Gastroenterology. Supplement|January 28, 2004
Whom and how to treat: weighing the costs and effectsB A van Hout
Health Economics|December 5, 2000
A Bayesian approach to economic analyses of clinical trials: the case of stenting versus balloon angioplastyM J Al, B A Van Hout
Nederlands Tijdschrift Voor Geneeskunde|November 12, 1994
[Is the use of helicopters with a trauma team in severely injured accident victims in The Netherlands cost effective? A modelling approach]B C Michel, B A van Hout
European Heart Journal|May 15, 2001
Cost-effectiveness of HMG coenzyme reductase inhibitors; whom to treat?B A van Hout, M L Simoons
European Heart Journal|November 1, 1995
Costs and effects of c7E3 in high risk PTCA patients. An indirect analysis for The NetherlandsB A van Hout, M L Simoons
European Heart Journal|August 3, 2001
Cost-efficacy in interventional cardiology; results from the EPISTENT study. Evaluation of Platelet IIb/IIIa Inhibitor For Stenting TrialJ E Zwart-van Rijkom, B A van Hout
Epilepsia|January 1, 1997
Current issues in the management of epilepsy: the impact of frequent seizures on cost of illness, quality of life, and mortalityG A Baker, L Nashef, B A van Hout
Bailliere'S Clinical Gastroenterology|September 1, 1994
Assessing the benefits of transplant servicesB C Michel, B A Van Hout, G J Bonsel
Heart (British Cardiac Society)|August 18, 2004
Sirolimus eluting stent implantation for patients with multivessel disease: rationale for the Arterial Revascularisation Therapies Study part II (ARTS II)P W Serruys, P A Lemos, B A van Hout, et al.
Pageof 7